Market revenue in 2023 | USD 837.5 million |
Market revenue in 2030 | USD 1,391.3 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | Formulation development |
Fastest growing segment | Formulation Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preformulation, Formulation Development |
Key market players worldwide | SGS, Intertek Group PLC, Recipharm, Lonza Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Element Solutions Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Catalent Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to formulation development outsourcing market will help companies and investors design strategic landscapes.
Formulation development was the largest segment with a revenue share of 76.81% in 2023. Horizon Databook has segmented the South Korea formulation development outsourcing market based on preformulation, formulation development covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea's favorable government policies in the biotechnology and biopharmaceutical industries, including a significant investment of around USD 1.7 billion in 2020 to boost biopharmaceutical R&D and production, make it a promising destination for formulation development outsourcing.
The Ministry of Food and Drug Safety's 5-year plan to enhance clinical trials in South Korea, along with the country's established infrastructure and competent workforce, are likely to boost the outsourcing market significantly.
South Korea's world-class research facilities, strong intellectual property protection laws, and regulatory framework for drug development make it an attractive option for pharmaceutical & biotech companies to outsource their formulation development work.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea formulation development outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into South Korea formulation development outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account